JP2007516200A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516200A5 JP2007516200A5 JP2006518343A JP2006518343A JP2007516200A5 JP 2007516200 A5 JP2007516200 A5 JP 2007516200A5 JP 2006518343 A JP2006518343 A JP 2006518343A JP 2006518343 A JP2006518343 A JP 2006518343A JP 2007516200 A5 JP2007516200 A5 JP 2007516200A5
- Authority
- JP
- Japan
- Prior art keywords
- azabicyclo
- spiro
- octane
- oxazolidine
- thiophen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 R 3 Chemical class 0.000 claims description 117
- 150000001875 compounds Chemical class 0.000 claims description 35
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 239000001257 hydrogen Substances 0.000 claims description 28
- 125000004122 cyclic group Chemical group 0.000 claims description 21
- 150000002431 hydrogen Chemical class 0.000 claims description 16
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 13
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 8
- 125000004434 sulfur atom Chemical group 0.000 claims description 8
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 7
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 claims description 4
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 7
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000006017 1-propenyl group Chemical group 0.000 claims 3
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- 230000006735 deficit Effects 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 3
- 125000006038 hexenyl group Chemical group 0.000 claims 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 3
- 125000002346 iodo group Chemical group I* 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 claims 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims 3
- TYAGAVRSOFABFO-UHFFFAOYSA-N spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound O1C(=O)NCC11C(CC2)CCN2C1 TYAGAVRSOFABFO-UHFFFAOYSA-N 0.000 claims 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 3
- ONLUCDBUROZPQZ-QGZVFWFLSA-N (5r)-3-(2-pyridin-3-yl-1,3-thiazol-4-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(N=1)=CSC=1C1=CC=CN=C1 ONLUCDBUROZPQZ-QGZVFWFLSA-N 0.000 claims 2
- PLUFRMLMVYJVRA-QGZVFWFLSA-N (5r)-3-(2-pyridin-3-yl-1,3-thiazol-5-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CN=C1C1=CC=CN=C1 PLUFRMLMVYJVRA-QGZVFWFLSA-N 0.000 claims 2
- YGFUQGIYPFXQRL-QGZVFWFLSA-N (5r)-3-(2-pyridin-4-yl-1,3-thiazol-4-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(N=1)=CSC=1C1=CC=NC=C1 YGFUQGIYPFXQRL-QGZVFWFLSA-N 0.000 claims 2
- YZXOXLVSNMAQQD-QGZVFWFLSA-N (5r)-3-(2-pyridin-4-yl-1,3-thiazol-5-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CN=C1C1=CC=NC=C1 YZXOXLVSNMAQQD-QGZVFWFLSA-N 0.000 claims 2
- JUXGDTBXNQMZFI-HXUWFJFHSA-N (5r)-3-[5-(3-methoxyphenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound COC1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 JUXGDTBXNQMZFI-HXUWFJFHSA-N 0.000 claims 2
- NJGIYZOSEBWUOK-LJQANCHMSA-N (5r)-3-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound FC(F)(F)OC1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 NJGIYZOSEBWUOK-LJQANCHMSA-N 0.000 claims 2
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 claims 2
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 claims 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 2
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 208000000044 Amnesia Diseases 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 2
- 208000028698 Cognitive impairment Diseases 0.000 claims 2
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 claims 2
- 208000023105 Huntington disease Diseases 0.000 claims 2
- 206010026749 Mania Diseases 0.000 claims 2
- 208000026139 Memory disease Diseases 0.000 claims 2
- 208000012902 Nervous system disease Diseases 0.000 claims 2
- 206010057852 Nicotine dependence Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 208000000323 Tourette Syndrome Diseases 0.000 claims 2
- 208000016620 Tourette disease Diseases 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 claims 2
- 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 claims 2
- 230000036506 anxiety Effects 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 2
- 208000028683 bipolar I disease Diseases 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 230000001713 cholinergic effect Effects 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 230000007812 deficiency Effects 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 230000006984 memory degeneration Effects 0.000 claims 2
- 208000023060 memory loss Diseases 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 208000020016 psychiatric disease Diseases 0.000 claims 2
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims 2
- 125000004944 pyrazin-3-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims 2
- 201000000980 schizophrenia Diseases 0.000 claims 2
- IQZSFDJPGKPJOF-UHFFFAOYSA-N spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole] Chemical compound C1N=COC11C(CC2)CCN2C1 IQZSFDJPGKPJOF-UHFFFAOYSA-N 0.000 claims 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 1
- IFLYPJZUNYFMGO-GOSISDBHSA-N (5r)-3-(2-phenyl-1,3-oxazol-4-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(N=1)=COC=1C1=CC=CC=C1 IFLYPJZUNYFMGO-GOSISDBHSA-N 0.000 claims 1
- WUPCJGFKGNIKCY-GOSISDBHSA-N (5r)-3-(2-phenyl-1,3-oxazol-5-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CN=C1C1=CC=CC=C1 WUPCJGFKGNIKCY-GOSISDBHSA-N 0.000 claims 1
- FDIWDKGCJZJCIU-GOSISDBHSA-N (5r)-3-(2-phenyl-1,3-thiazol-4-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(N=1)=CSC=1C1=CC=CC=C1 FDIWDKGCJZJCIU-GOSISDBHSA-N 0.000 claims 1
- APXGUGRSIUKRGK-GOSISDBHSA-N (5r)-3-(2-phenyl-1,3-thiazol-5-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CN=C1C1=CC=CC=C1 APXGUGRSIUKRGK-GOSISDBHSA-N 0.000 claims 1
- WSLDNOHFXKPNIO-QGZVFWFLSA-N (5r)-3-(2-pyridin-2-yl-1,3-oxazol-4-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(N=1)=COC=1C1=CC=CC=N1 WSLDNOHFXKPNIO-QGZVFWFLSA-N 0.000 claims 1
- HOBPHYIQUKCPCO-QGZVFWFLSA-N (5r)-3-(2-pyridin-2-yl-1,3-oxazol-5-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CN=C1C1=CC=CC=N1 HOBPHYIQUKCPCO-QGZVFWFLSA-N 0.000 claims 1
- FJWRCVGCNDWSSL-QGZVFWFLSA-N (5r)-3-(2-pyridin-2-yl-1,3-thiazol-4-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(N=1)=CSC=1C1=CC=CC=N1 FJWRCVGCNDWSSL-QGZVFWFLSA-N 0.000 claims 1
- ZDLKAYLKKMGRRW-QGZVFWFLSA-N (5r)-3-(2-pyridin-2-yl-1,3-thiazol-5-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CN=C1C1=CC=CC=N1 ZDLKAYLKKMGRRW-QGZVFWFLSA-N 0.000 claims 1
- RSXFMXZXOJILPW-GOSISDBHSA-N (5r)-3-(4-phenyl-1,3-oxazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=NC=1C1=CC=CC=C1 RSXFMXZXOJILPW-GOSISDBHSA-N 0.000 claims 1
- BMEZFTQMRDMRBL-LJQANCHMSA-N (5r)-3-(4-phenylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CC=CC=C1 BMEZFTQMRDMRBL-LJQANCHMSA-N 0.000 claims 1
- LABSFGCWQZGKGU-LJQANCHMSA-N (5r)-3-(4-phenylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=CC=CC=C1 LABSFGCWQZGKGU-LJQANCHMSA-N 0.000 claims 1
- QEMJXXVNTVTTKE-QGZVFWFLSA-N (5r)-3-(4-pyridin-2-yl-1,3-oxazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=NC=1C1=CC=CC=N1 QEMJXXVNTVTTKE-QGZVFWFLSA-N 0.000 claims 1
- ZCQQZMRANWLMDH-GOSISDBHSA-N (5r)-3-(4-pyridin-2-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CC=CC=N1 ZCQQZMRANWLMDH-GOSISDBHSA-N 0.000 claims 1
- ZFRHYOKFWFIRAP-GOSISDBHSA-N (5r)-3-(4-pyridin-2-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=CC=CC=N1 ZFRHYOKFWFIRAP-GOSISDBHSA-N 0.000 claims 1
- HOQYAUXAHINJML-QGZVFWFLSA-N (5r)-3-(4-pyridin-3-yl-1,3-thiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=NC=1C1=CC=CN=C1 HOQYAUXAHINJML-QGZVFWFLSA-N 0.000 claims 1
- STNOSEGZBWWTLA-GOSISDBHSA-N (5r)-3-(4-pyridin-3-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CC=CN=C1 STNOSEGZBWWTLA-GOSISDBHSA-N 0.000 claims 1
- XBBILQSGYGHSNM-QGZVFWFLSA-N (5r)-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=NC=1C1=CC=NC=C1 XBBILQSGYGHSNM-QGZVFWFLSA-N 0.000 claims 1
- UKAYATXHBBUJRY-GOSISDBHSA-N (5r)-3-(4-pyridin-4-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CC=NC=C1 UKAYATXHBBUJRY-GOSISDBHSA-N 0.000 claims 1
- IHHPOAGKJCODST-GOSISDBHSA-N (5r)-3-(4-pyridin-4-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=CC=NC=C1 IHHPOAGKJCODST-GOSISDBHSA-N 0.000 claims 1
- HYPWRICQQUBVDS-QGZVFWFLSA-N (5r)-3-(4-thiophen-2-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CC=CS1 HYPWRICQQUBVDS-QGZVFWFLSA-N 0.000 claims 1
- SSLHXXXNKBBFHI-QGZVFWFLSA-N (5r)-3-(4-thiophen-2-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=CC=CS1 SSLHXXXNKBBFHI-QGZVFWFLSA-N 0.000 claims 1
- XMDIXXWASPKCKO-QGZVFWFLSA-N (5r)-3-(4-thiophen-3-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C=1C=CSC=1 XMDIXXWASPKCKO-QGZVFWFLSA-N 0.000 claims 1
- CFPZSVNYWRYXRI-QGZVFWFLSA-N (5r)-3-(4-thiophen-3-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C=1C=CSC=1 CFPZSVNYWRYXRI-QGZVFWFLSA-N 0.000 claims 1
- OYKDRKYQVZZHHK-HSZRJFAPSA-N (5r)-3-(5-naphthalen-2-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2C=C3C=CC=CC3=CC=2)C1 OYKDRKYQVZZHHK-HSZRJFAPSA-N 0.000 claims 1
- ZNKIRORULJTACP-QGZVFWFLSA-N (5r)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=NN=C1C1=CC=CC=C1 ZNKIRORULJTACP-QGZVFWFLSA-N 0.000 claims 1
- DAGYOMVTWZUKCM-GOSISDBHSA-N (5r)-3-(5-phenyl-1,3-oxazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=NC=C1C1=CC=CC=C1 DAGYOMVTWZUKCM-GOSISDBHSA-N 0.000 claims 1
- RIJZDPAGZCYNIZ-LJQANCHMSA-N (5r)-3-(5-phenylfuran-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CC=CC=C1 RIJZDPAGZCYNIZ-LJQANCHMSA-N 0.000 claims 1
- QAUNMLMGCGOLRW-LJQANCHMSA-N (5r)-3-(5-phenylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CC=CC=C1 QAUNMLMGCGOLRW-LJQANCHMSA-N 0.000 claims 1
- PXLQLMHLCPUJEE-LJQANCHMSA-N (5r)-3-(5-phenylthiophen-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CC=CC=C1 PXLQLMHLCPUJEE-LJQANCHMSA-N 0.000 claims 1
- QDXIYBFEDOTVMW-MRXNPFEDSA-N (5r)-3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=NN=C1C1=CC=CC=N1 QDXIYBFEDOTVMW-MRXNPFEDSA-N 0.000 claims 1
- AJSQEOCKHDRTEZ-QGZVFWFLSA-N (5r)-3-(5-pyridin-2-yl-1,3-oxazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=NC=C1C1=CC=CC=N1 AJSQEOCKHDRTEZ-QGZVFWFLSA-N 0.000 claims 1
- IPOOMQUHHNTELR-GOSISDBHSA-N (5r)-3-(5-pyridin-2-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=CC=CC=N1 IPOOMQUHHNTELR-GOSISDBHSA-N 0.000 claims 1
- XQDQRGMEQFOARI-GOSISDBHSA-N (5r)-3-(5-pyridin-2-ylfuran-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CC=CC=N1 XQDQRGMEQFOARI-GOSISDBHSA-N 0.000 claims 1
- QKKSSPQAFKAXPR-GOSISDBHSA-N (5r)-3-(5-pyridin-2-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CC=CC=N1 QKKSSPQAFKAXPR-GOSISDBHSA-N 0.000 claims 1
- AHQIHLJDDXRCBX-GOSISDBHSA-N (5r)-3-(5-pyridin-2-ylthiophen-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CC=CC=N1 AHQIHLJDDXRCBX-GOSISDBHSA-N 0.000 claims 1
- FWQJQLWSRSFXRE-MRXNPFEDSA-N (5r)-3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=NN=C1C1=CC=CN=C1 FWQJQLWSRSFXRE-MRXNPFEDSA-N 0.000 claims 1
- FZFBZVJHXGGUOX-MRXNPFEDSA-N (5r)-3-(5-pyridin-3-yl-1,3,4-thiadiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=NN=C1C1=CC=CN=C1 FZFBZVJHXGGUOX-MRXNPFEDSA-N 0.000 claims 1
- BYOIBMRWDGAOMU-QGZVFWFLSA-N (5r)-3-(5-pyridin-3-yl-1,3-thiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=NC=C1C1=CC=CN=C1 BYOIBMRWDGAOMU-QGZVFWFLSA-N 0.000 claims 1
- KPVDXUFUFDSIQW-GOSISDBHSA-N (5r)-3-(5-pyridin-3-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=CC=CN=C1 KPVDXUFUFDSIQW-GOSISDBHSA-N 0.000 claims 1
- NNYOLBRVKKYQIZ-GOSISDBHSA-N (5r)-3-(5-pyridin-3-ylfuran-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CC=CN=C1 NNYOLBRVKKYQIZ-GOSISDBHSA-N 0.000 claims 1
- ABONEISZOLWBCL-GOSISDBHSA-N (5r)-3-(5-pyridin-3-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CC=CN=C1 ABONEISZOLWBCL-GOSISDBHSA-N 0.000 claims 1
- SNNGVFJTWGBXMS-GOSISDBHSA-N (5r)-3-(5-pyridin-3-ylthiophen-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CC=CN=C1 SNNGVFJTWGBXMS-GOSISDBHSA-N 0.000 claims 1
- BECJJRSHZNAZTQ-MRXNPFEDSA-N (5r)-3-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=NN=C1C1=CC=NC=C1 BECJJRSHZNAZTQ-MRXNPFEDSA-N 0.000 claims 1
- VBLDVIZDDSSBLZ-QGZVFWFLSA-N (5r)-3-(5-pyridin-4-yl-1,3-thiazol-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=NC=C1C1=CC=NC=C1 VBLDVIZDDSSBLZ-QGZVFWFLSA-N 0.000 claims 1
- WDMUHVIWABZWQG-GOSISDBHSA-N (5r)-3-(5-pyridin-4-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=CC=NC=C1 WDMUHVIWABZWQG-GOSISDBHSA-N 0.000 claims 1
- GGQAXZVZTOUDQU-GOSISDBHSA-N (5r)-3-(5-pyridin-4-ylfuran-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CC=NC=C1 GGQAXZVZTOUDQU-GOSISDBHSA-N 0.000 claims 1
- SMHKVSJKDIFJHN-GOSISDBHSA-N (5r)-3-(5-pyridin-4-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CC=NC=C1 SMHKVSJKDIFJHN-GOSISDBHSA-N 0.000 claims 1
- HRPBSJNJPWAPHW-GOSISDBHSA-N (5r)-3-(5-pyridin-4-ylthiophen-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CC=NC=C1 HRPBSJNJPWAPHW-GOSISDBHSA-N 0.000 claims 1
- NPIPJMRNEJUMNH-QGZVFWFLSA-N (5r)-3-(5-pyrimidin-2-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=NC=CC=N1 NPIPJMRNEJUMNH-QGZVFWFLSA-N 0.000 claims 1
- ZHCJDYXUQXZKHJ-QGZVFWFLSA-N (5r)-3-(5-pyrimidin-4-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CC=NC=N1 ZHCJDYXUQXZKHJ-QGZVFWFLSA-N 0.000 claims 1
- IQEHPOBKDBHAIG-QGZVFWFLSA-N (5r)-3-(5-pyrimidin-5-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CN=CN=C1 IQEHPOBKDBHAIG-QGZVFWFLSA-N 0.000 claims 1
- QIMMRUNOHPAAMN-JOCHJYFZSA-N (5r)-3-(5-quinolin-2-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2N=C3C=CC=CC3=CC=2)C1 QIMMRUNOHPAAMN-JOCHJYFZSA-N 0.000 claims 1
- NQFSQJXUWZMFHJ-JOCHJYFZSA-N (5r)-3-(5-quinolin-3-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2C=C3C=CC=CC3=NC=2)C1 NQFSQJXUWZMFHJ-JOCHJYFZSA-N 0.000 claims 1
- ILUZTUFUDSONFD-JOCHJYFZSA-N (5r)-3-(5-quinolin-4-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2C3=CC=CC=C3N=CC=2)C1 ILUZTUFUDSONFD-JOCHJYFZSA-N 0.000 claims 1
- AFNLXUXORBZXGT-JOCHJYFZSA-N (5r)-3-(5-quinolin-5-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2C3=CC=CN=C3C=CC=2)C1 AFNLXUXORBZXGT-JOCHJYFZSA-N 0.000 claims 1
- WQGNQSRCHYQWAW-JOCHJYFZSA-N (5r)-3-(5-quinolin-6-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2C=C3C=CC=NC3=CC=2)C1 WQGNQSRCHYQWAW-JOCHJYFZSA-N 0.000 claims 1
- SEPYBTXTAUUVJM-JOCHJYFZSA-N (5r)-3-(5-quinolin-7-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2C=C3N=CC=CC3=CC=2)C1 SEPYBTXTAUUVJM-JOCHJYFZSA-N 0.000 claims 1
- CBTLWZKPJUYJOO-JOCHJYFZSA-N (5r)-3-(5-quinolin-8-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2C3=NC=CC=C3C=CC=2)C1 CBTLWZKPJUYJOO-JOCHJYFZSA-N 0.000 claims 1
- JGDMIDUBMTZYDZ-QGZVFWFLSA-N (5r)-3-(5-thiophen-2-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=CC=CS1 JGDMIDUBMTZYDZ-QGZVFWFLSA-N 0.000 claims 1
- OXGSXHYIHDSUPE-QGZVFWFLSA-N (5r)-3-(5-thiophen-2-ylfuran-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CC=CS1 OXGSXHYIHDSUPE-QGZVFWFLSA-N 0.000 claims 1
- RAKZHRQIHNYDRY-QGZVFWFLSA-N (5r)-3-(5-thiophen-2-ylthiophen-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CC=CS1 RAKZHRQIHNYDRY-QGZVFWFLSA-N 0.000 claims 1
- WPJIGRXRLOGVHO-QGZVFWFLSA-N (5r)-3-(5-thiophen-3-ylfuran-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C=1C=CSC=1 WPJIGRXRLOGVHO-QGZVFWFLSA-N 0.000 claims 1
- UJMGUUWBDIPUCQ-QGZVFWFLSA-N (5r)-3-(5-thiophen-3-ylfuran-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C=1C=CSC=1 UJMGUUWBDIPUCQ-QGZVFWFLSA-N 0.000 claims 1
- XTRRCXIRWJJOSX-QGZVFWFLSA-N (5r)-3-(5-thiophen-3-ylthiophen-2-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C=1C=CSC=1 XTRRCXIRWJJOSX-QGZVFWFLSA-N 0.000 claims 1
- FJPHZJGPVQQDFI-QGZVFWFLSA-N (5r)-3-(5-thiophen-3-ylthiophen-3-yl)spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C=1C=CSC=1 FJPHZJGPVQQDFI-QGZVFWFLSA-N 0.000 claims 1
- ZXMRWURKHLFORI-MRXNPFEDSA-N (5r)-3-[4-(1,3-thiazol-2-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=NC=CS1 ZXMRWURKHLFORI-MRXNPFEDSA-N 0.000 claims 1
- JZMRLKCRSJSQKP-MRXNPFEDSA-N (5r)-3-[4-(1,3-thiazol-2-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=NC=CS1 JZMRLKCRSJSQKP-MRXNPFEDSA-N 0.000 claims 1
- PFIJVHUMKRNKQW-MRXNPFEDSA-N (5r)-3-[4-(1,3-thiazol-4-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CSC=N1 PFIJVHUMKRNKQW-MRXNPFEDSA-N 0.000 claims 1
- HWKOGMDTJUNMJM-MRXNPFEDSA-N (5r)-3-[4-(1,3-thiazol-4-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=CSC=N1 HWKOGMDTJUNMJM-MRXNPFEDSA-N 0.000 claims 1
- ILTGLZAWYJYOGG-MRXNPFEDSA-N (5r)-3-[4-(1,3-thiazol-5-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CN=CS1 ILTGLZAWYJYOGG-MRXNPFEDSA-N 0.000 claims 1
- MAAZOQQGMGBMPV-MRXNPFEDSA-N (5r)-3-[4-(1,3-thiazol-5-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=CN=CS1 MAAZOQQGMGBMPV-MRXNPFEDSA-N 0.000 claims 1
- YUDOPZDZTWDFKA-QGZVFWFLSA-N (5r)-3-[4-(furan-2-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C1=CC=CO1 YUDOPZDZTWDFKA-QGZVFWFLSA-N 0.000 claims 1
- MJAUISVULZRRRC-QGZVFWFLSA-N (5r)-3-[4-(furan-2-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C1=CC=CO1 MJAUISVULZRRRC-QGZVFWFLSA-N 0.000 claims 1
- VYMKMDHOSBNTAC-QGZVFWFLSA-N (5r)-3-[4-(furan-3-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(OC=1)=CC=1C=1C=COC=1 VYMKMDHOSBNTAC-QGZVFWFLSA-N 0.000 claims 1
- OLSLYYJZGRPRIO-QGZVFWFLSA-N (5r)-3-[4-(furan-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(SC=1)=CC=1C=1C=COC=1 OLSLYYJZGRPRIO-QGZVFWFLSA-N 0.000 claims 1
- AOCAOOAPSKILSD-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-2-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=NC=CS1 AOCAOOAPSKILSD-MRXNPFEDSA-N 0.000 claims 1
- PKCNBBCSHLHBNW-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-2-yl)furan-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=NC=CS1 PKCNBBCSHLHBNW-MRXNPFEDSA-N 0.000 claims 1
- VQDDTGDOFAVWQR-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-2-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=NC=CS1 VQDDTGDOFAVWQR-MRXNPFEDSA-N 0.000 claims 1
- SLBMLSQBOJBIDR-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-2-yl)thiophen-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=NC=CS1 SLBMLSQBOJBIDR-MRXNPFEDSA-N 0.000 claims 1
- HXBSXJZXBCHRMU-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-4-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=CSC=N1 HXBSXJZXBCHRMU-MRXNPFEDSA-N 0.000 claims 1
- MORFNAJGZXGODW-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-4-yl)furan-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CSC=N1 MORFNAJGZXGODW-MRXNPFEDSA-N 0.000 claims 1
- ZSDDFCLPVLBIAH-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-4-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CSC=N1 ZSDDFCLPVLBIAH-MRXNPFEDSA-N 0.000 claims 1
- YLSLCKHNEKNVOS-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-4-yl)thiophen-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CSC=N1 YLSLCKHNEKNVOS-MRXNPFEDSA-N 0.000 claims 1
- KHAYKOWOTIABJP-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-5-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=CN=CS1 KHAYKOWOTIABJP-MRXNPFEDSA-N 0.000 claims 1
- DYTLAPNXUVQQGH-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-5-yl)furan-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CN=CS1 DYTLAPNXUVQQGH-MRXNPFEDSA-N 0.000 claims 1
- GAPGOBONZPQUTH-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-5-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C1=CN=CS1 GAPGOBONZPQUTH-MRXNPFEDSA-N 0.000 claims 1
- AOLRWIAKSLDQES-MRXNPFEDSA-N (5r)-3-[5-(1,3-thiazol-5-yl)thiophen-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CN=CS1 AOLRWIAKSLDQES-MRXNPFEDSA-N 0.000 claims 1
- JVLLJDORJMRDJS-OAQYLSRUSA-N (5r)-3-[5-(1-benzofuran-2-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2OC3=CC=CC=C3C=2)C1 JVLLJDORJMRDJS-OAQYLSRUSA-N 0.000 claims 1
- ISCNIRYSOTVWHA-OAQYLSRUSA-N (5r)-3-[5-(1-benzothiophen-2-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1N(CC2)CCC2[C@@]11OC(=O)N(C=2SC(=CC=2)C=2SC3=CC=CC=C3C=2)C1 ISCNIRYSOTVWHA-OAQYLSRUSA-N 0.000 claims 1
- DWCKDHPFTMPYOU-GOSISDBHSA-N (5r)-3-[5-(2-aminopyridin-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound NC1=NC=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 DWCKDHPFTMPYOU-GOSISDBHSA-N 0.000 claims 1
- DCZUTBSVPUIWHJ-LJQANCHMSA-N (5r)-3-[5-(2-chlorophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound ClC1=CC=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 DCZUTBSVPUIWHJ-LJQANCHMSA-N 0.000 claims 1
- DIPSNHUQDYWIDE-GOSISDBHSA-N (5r)-3-[5-(2-chloropyridin-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound ClC1=NC=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 DIPSNHUQDYWIDE-GOSISDBHSA-N 0.000 claims 1
- RNOHOPZXDPXVBB-LJQANCHMSA-N (5r)-3-[5-(2-fluorophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound FC1=CC=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 RNOHOPZXDPXVBB-LJQANCHMSA-N 0.000 claims 1
- JXDDWHFKLYAUFW-GOSISDBHSA-N (5r)-3-[5-(2-fluoropyridin-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound FC1=NC=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 JXDDWHFKLYAUFW-GOSISDBHSA-N 0.000 claims 1
- PYKDBADKZJQRRG-LJQANCHMSA-N (5r)-3-[5-(2-methoxypyridin-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound COC1=NC=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 PYKDBADKZJQRRG-LJQANCHMSA-N 0.000 claims 1
- AHQXZSZIUJGLBU-LJQANCHMSA-N (5r)-3-[5-(3,4-dichlorophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 AHQXZSZIUJGLBU-LJQANCHMSA-N 0.000 claims 1
- NMFNUIHWCWJGIB-LJQANCHMSA-N (5r)-3-[5-(3-aminophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound NC1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 NMFNUIHWCWJGIB-LJQANCHMSA-N 0.000 claims 1
- DBZHCJXMZWPZCM-LJQANCHMSA-N (5r)-3-[5-(3-chlorophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound ClC1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 DBZHCJXMZWPZCM-LJQANCHMSA-N 0.000 claims 1
- BNPDFAXJDVWMGH-LJQANCHMSA-N (5r)-3-[5-(3-fluorophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound FC1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 BNPDFAXJDVWMGH-LJQANCHMSA-N 0.000 claims 1
- CQWWTYBMZWDLCL-HXUWFJFHSA-N (5r)-3-[5-(3-methylphenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound CC1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 CQWWTYBMZWDLCL-HXUWFJFHSA-N 0.000 claims 1
- UPUYEOGQXYBGLL-JOCHJYFZSA-N (5r)-3-[5-(3-propan-2-yloxyphenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound CC(C)OC1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 UPUYEOGQXYBGLL-JOCHJYFZSA-N 0.000 claims 1
- QQYFTFYSZIYWBO-LJQANCHMSA-N (5r)-3-[5-(4-chlorophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1=CC(Cl)=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 QQYFTFYSZIYWBO-LJQANCHMSA-N 0.000 claims 1
- LVLIHKDYGVLEFI-LJQANCHMSA-N (5r)-3-[5-(4-fluorophenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1=CC(F)=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 LVLIHKDYGVLEFI-LJQANCHMSA-N 0.000 claims 1
- BRTUKTQOEYNCMR-HXUWFJFHSA-N (5r)-3-[5-(4-methoxyphenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1=CC(OC)=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 BRTUKTQOEYNCMR-HXUWFJFHSA-N 0.000 claims 1
- YRMKEEIZIGQAPM-HXUWFJFHSA-N (5r)-3-[5-(4-methylphenyl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1=CC(C)=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 YRMKEEIZIGQAPM-HXUWFJFHSA-N 0.000 claims 1
- DPOWXCFCYTWPMD-GOSISDBHSA-N (5r)-3-[5-(5-aminopyridin-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound NC1=CN=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 DPOWXCFCYTWPMD-GOSISDBHSA-N 0.000 claims 1
- BTJRBFBDPAQTNL-GOSISDBHSA-N (5r)-3-[5-(5-chloropyridin-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound ClC1=CN=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 BTJRBFBDPAQTNL-GOSISDBHSA-N 0.000 claims 1
- ZXRXSWLRXBAJQY-LJQANCHMSA-N (5r)-3-[5-(5-methoxypyridin-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound COC1=CN=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 ZXRXSWLRXBAJQY-LJQANCHMSA-N 0.000 claims 1
- MYXQVXHFCYGNIJ-QGZVFWFLSA-N (5r)-3-[5-(furan-2-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C1=CC=CO1 MYXQVXHFCYGNIJ-QGZVFWFLSA-N 0.000 claims 1
- KGCPFFANNBMIBK-QGZVFWFLSA-N (5r)-3-[5-(furan-2-yl)furan-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C1=CC=CO1 KGCPFFANNBMIBK-QGZVFWFLSA-N 0.000 claims 1
- ADRCYMKPCISTNJ-QGZVFWFLSA-N (5r)-3-[5-(furan-2-yl)thiophen-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C1=CC=CO1 ADRCYMKPCISTNJ-QGZVFWFLSA-N 0.000 claims 1
- FDESMSOITOBLPD-QGZVFWFLSA-N (5r)-3-[5-(furan-3-yl)furan-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(O1)=CC=C1C=1C=COC=1 FDESMSOITOBLPD-QGZVFWFLSA-N 0.000 claims 1
- AFCCRJQSRUGXTM-QGZVFWFLSA-N (5r)-3-[5-(furan-3-yl)furan-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=COC=1C=1C=COC=1 AFCCRJQSRUGXTM-QGZVFWFLSA-N 0.000 claims 1
- NIYWNSRALWZGPS-QGZVFWFLSA-N (5r)-3-[5-(furan-3-yl)thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(S1)=CC=C1C=1C=COC=1 NIYWNSRALWZGPS-QGZVFWFLSA-N 0.000 claims 1
- JKQNSKVKWGUSOH-QGZVFWFLSA-N (5r)-3-[5-(furan-3-yl)thiophen-3-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C([C@@]1(OC2=O)C3CCN(CC3)C1)N2C(C=1)=CSC=1C=1C=COC=1 JKQNSKVKWGUSOH-QGZVFWFLSA-N 0.000 claims 1
- USFWQRYAQSQELX-HXUWFJFHSA-N (5r)-3-[5-[2-(dimethylamino)pyridin-3-yl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound CN(C)C1=NC=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 USFWQRYAQSQELX-HXUWFJFHSA-N 0.000 claims 1
- IZHVZBZAPVQIRW-XMMPIXPASA-N (5r)-3-[5-[3-(morpholine-4-carbonyl)phenyl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C=1C=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=CC=1C(=O)N1CCOCC1 IZHVZBZAPVQIRW-XMMPIXPASA-N 0.000 claims 1
- RPVJBEHOCBUJMU-RUZDIDTESA-N (5r)-3-[5-[3-(piperidine-1-carbonyl)phenyl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C=1C=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=CC=1C(=O)N1CCCCC1 RPVJBEHOCBUJMU-RUZDIDTESA-N 0.000 claims 1
- IGYYOQKUEIJCPQ-LJQANCHMSA-N (5r)-3-[5-[3-(trifluoromethyl)phenyl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound FC(F)(F)C1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 IGYYOQKUEIJCPQ-LJQANCHMSA-N 0.000 claims 1
- KQWPMSAVCVHCFR-LJQANCHMSA-N (5r)-3-[5-[4-(trifluoromethoxy)phenyl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 KQWPMSAVCVHCFR-LJQANCHMSA-N 0.000 claims 1
- FODDZBMXKBWAFT-LJQANCHMSA-N (5r)-3-[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CC=C(N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)S1 FODDZBMXKBWAFT-LJQANCHMSA-N 0.000 claims 1
- WIYJRYRRDWEIGZ-HXUWFJFHSA-N (5r)-3-[5-[5-(dimethylamino)pyridin-3-yl]thiophen-2-yl]spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one Chemical compound CN(C)C1=CN=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 WIYJRYRRDWEIGZ-HXUWFJFHSA-N 0.000 claims 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 1
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 1
- 208000025569 Tobacco Use disease Diseases 0.000 claims 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical group [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 235000019788 craving Nutrition 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 claims 1
- 201000003723 learning disability Diseases 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- RRGRHIOXMUNYFJ-XMMPIXPASA-N n,n-diethyl-3-[5-[(5r)-2-oxospiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-3-yl]thiophen-2-yl]benzamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 RRGRHIOXMUNYFJ-XMMPIXPASA-N 0.000 claims 1
- LDUNGHBFRJDIEB-JOCHJYFZSA-N n,n-dimethyl-3-[5-[(5r)-2-oxospiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-3-yl]thiophen-2-yl]benzamide Chemical compound CN(C)C(=O)C1=CC=CC(C=2SC(=CC=2)N2C(O[C@@]3(C4CCN(CC4)C3)C2)=O)=C1 LDUNGHBFRJDIEB-JOCHJYFZSA-N 0.000 claims 1
- 229960002715 nicotine Drugs 0.000 claims 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000005586 smoking cessation Effects 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- 210000000225 synapse Anatomy 0.000 claims 1
- 230000000946 synaptic effect Effects 0.000 claims 1
- 230000005062 synaptic transmission Effects 0.000 claims 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 229910052722 tritium Inorganic materials 0.000 claims 1
- 125000002524 organometallic group Chemical group 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 150000001491 aromatic compounds Chemical class 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48552303P | 2003-07-08 | 2003-07-08 | |
| PCT/GB2004/002904 WO2005005435A1 (en) | 2003-07-08 | 2004-07-06 | Spiro ′1-azabicyclo ′2.2.2!octan-3,5′-oxazolidin -2′-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007516200A JP2007516200A (ja) | 2007-06-21 |
| JP2007516200A5 true JP2007516200A5 (https=) | 2007-08-09 |
Family
ID=34062082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006518343A Pending JP2007516200A (ja) | 2003-07-08 | 2004-07-06 | α７ニコチン性アセチルコリン受容体に親和性を有するスピロ［１−アザビシクロ［２，２，２］オクタン−３，５’−オキサゾリジン］−２’−オン誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7514567B2 (https=) |
| EP (1) | EP1654264A1 (https=) |
| JP (1) | JP2007516200A (https=) |
| KR (1) | KR20060057569A (https=) |
| CN (1) | CN1829721A (https=) |
| AR (1) | AR045040A1 (https=) |
| AU (1) | AU2004255920B2 (https=) |
| BR (1) | BRPI0412382A (https=) |
| CA (1) | CA2531510A1 (https=) |
| IL (1) | IL172762A0 (https=) |
| MX (1) | MXPA06000231A (https=) |
| NO (1) | NO20060612L (https=) |
| NZ (1) | NZ545132A (https=) |
| SA (1) | SA04250212B1 (https=) |
| TW (1) | TW200524942A (https=) |
| WO (1) | WO2005005435A1 (https=) |
| ZA (1) | ZA200600154B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007006743A (es) * | 2004-12-15 | 2007-07-09 | Astrazeneca Ab | Ligandos del receptor de acetilcolina nicotinica. |
| WO2008021309A1 (en) | 2006-08-15 | 2008-02-21 | Wyeth | Imidazolidin-2-one derivatives useful as pr modulators |
| WO2008021338A2 (en) | 2006-08-15 | 2008-02-21 | Wyeth | Tricyclic oxazolidone derivatives useful as pr modulators |
| TW200815428A (en) | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
| US7538107B2 (en) | 2006-08-15 | 2009-05-26 | Wyeth | Oxazinan-2-one derivatives useful as PR modulators |
| US7649007B2 (en) | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
| US20100105685A1 (en) * | 2006-10-03 | 2010-04-29 | Galleon Pharmaceuticals, Inc. | S-Nitrosothiol Compounds and Related Derivatives |
| SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| US8309577B2 (en) | 2008-04-23 | 2012-11-13 | Bristol-Myers Squibb Company | Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands |
| US7863291B2 (en) * | 2008-04-23 | 2011-01-04 | Bristol-Myers Squibb Company | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| EP2583556B1 (de) * | 2008-07-17 | 2016-01-20 | Bayer CropScience AG | Heterocyclische Verbindungen als Schädlingsbekämpfungsmittel |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| UA107791C2 (en) * | 2009-05-05 | 2015-02-25 | Dow Agrosciences Llc | Pesticidal compositions |
| US8759550B2 (en) | 2009-08-27 | 2014-06-24 | Yeda Research And Development Co. Ltd. | Oligo- and polyfurans, preparation and uses thereof |
| US8278320B2 (en) | 2009-10-28 | 2012-10-02 | Bristol-Myers Squibb Company | Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| WO2011056573A1 (en) | 2009-10-28 | 2011-05-12 | Bristol-Myers Squibb Company | Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| EP2558458B1 (de) | 2010-04-16 | 2017-09-06 | Bayer Intellectual Property GmbH | Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel |
| CN103025744A (zh) | 2010-04-30 | 2013-04-03 | 百时美施贵宝公司 | 作为α-7烟碱乙酰胆碱受体配体前药的氮杂二环胺N-氧化物化合物 |
| MA34462B1 (fr) | 2010-07-22 | 2013-08-01 | Novartis Ag | Composes de thiophene 2,3,5- trisubstitues et leurs utilisations |
| BR112013009823A2 (pt) | 2010-10-22 | 2016-07-05 | Bayer Ip Gmbh | novos compostos heterocíclicos como pesticidas |
| WO2013138617A1 (en) | 2012-03-16 | 2013-09-19 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
| JP2016503395A (ja) | 2012-10-31 | 2016-02-04 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 病害生物防除剤としての複素環化合物 |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| TWI703133B (zh) | 2014-12-23 | 2020-09-01 | 美商艾克斯基製藥公司 | ３,５-二胺基吡唑激酶抑制劑 |
| MX388576B (es) | 2016-06-07 | 2025-03-20 | Jacobio Pharmaceuticals Co Ltd | Derivados heterociclicos novedosos utiles como inhibidores de shp2. |
| EA202190196A1 (ru) | 2017-03-23 | 2021-08-31 | Джакобио Фармасьютикалс Ко., Лтд. | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 |
| US20210393623A1 (en) | 2018-09-26 | 2021-12-23 | Jacobio Pharmaceuticals Co., Ltd. | Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855290A (en) * | 1985-05-10 | 1989-08-08 | State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research | Derivatives of quinuclidine |
| ATE192157T1 (de) * | 1994-08-24 | 2000-05-15 | Astra Ab | Therapeutisch verwendbare spiro-azabicyclische verbindungen |
| AU2001241056A1 (en) * | 2000-03-09 | 2001-09-17 | Mitsubishi Pharma Corporation | Spiro compounds, process for preparing the same and use thereof as drugs |
-
2004
- 2004-07-06 CN CNA2004800218491A patent/CN1829721A/zh active Pending
- 2004-07-06 MX MXPA06000231A patent/MXPA06000231A/es active IP Right Grant
- 2004-07-06 AU AU2004255920A patent/AU2004255920B2/en not_active Ceased
- 2004-07-06 KR KR1020067000400A patent/KR20060057569A/ko not_active Ceased
- 2004-07-06 US US10/563,271 patent/US7514567B2/en not_active Expired - Fee Related
- 2004-07-06 BR BRPI0412382-4A patent/BRPI0412382A/pt not_active IP Right Cessation
- 2004-07-06 EP EP04743249A patent/EP1654264A1/en not_active Withdrawn
- 2004-07-06 WO PCT/GB2004/002904 patent/WO2005005435A1/en not_active Ceased
- 2004-07-06 CA CA002531510A patent/CA2531510A1/en not_active Abandoned
- 2004-07-06 JP JP2006518343A patent/JP2007516200A/ja active Pending
- 2004-07-06 NZ NZ545132A patent/NZ545132A/en unknown
- 2004-07-07 AR ARP040102394A patent/AR045040A1/es not_active Application Discontinuation
- 2004-07-08 TW TW093120518A patent/TW200524942A/zh unknown
- 2004-07-11 SA SA04250212A patent/SA04250212B1/ar unknown
-
2005
- 2005-12-22 IL IL172762A patent/IL172762A0/en unknown
-
2006
- 2006-01-06 ZA ZA200600154A patent/ZA200600154B/en unknown
- 2006-02-08 NO NO20060612A patent/NO20060612L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007516200A5 (https=) | ||
| AU2004255920B2 (en) | Spiro [1-azabicyclo [2.2.2] octan-3,5'-oxazolidin]-2'-one derivatives with affinity to the alpha7 nicotinic acetylcholine receptor | |
| TWI284639B (en) | A compound having thrombopoietin receptor agonistic effect | |
| US8367706B2 (en) | Inhibitors of janus kinases | |
| TWI835770B (zh) | 心肌節抑制劑 | |
| AU2011205283B2 (en) | Compounds and methods | |
| JP2005527588A5 (https=) | ||
| NZ577474A (en) | Azatricyclo[3.3.1.1]decane derivatives and their uses as nicotinic acetylcholine receptors ligands | |
| JP2006507241A5 (https=) | ||
| JP2005534624A5 (https=) | ||
| RU2441868C2 (ru) | Аза-кольцевое соединение с внутренним мостиком | |
| JP2024056755A5 (https=) | ||
| JP2014520885A5 (https=) | ||
| CN109153649A (zh) | 烟碱乙酰胆碱受体的变构调节剂 | |
| TW201020256A (en) | Inhibitors of beta-secretase | |
| JP2015503502A (ja) | Ｍｃｈ受容体拮抗剤としてのベンゾイミダゾール誘導体 | |
| JP6466937B2 (ja) | 三環式ピペリジン化合物 | |
| AU2018386464B2 (en) | Small molecule modulators of the BTB domain of Keap1 | |
| RU2006125636A (ru) | Лиганды никотиновых рецепторов ацетилхолина | |
| JP2007506723A5 (https=) |